Erratum: Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV (American Society for Microbiology (2022) 66:12 (e00584-22) DOI: 10.1128/aac.00584-22)
Banda CG., Nkosi D., Allen E., Workman L., Madanitsa M., Chirwa M., Kapulula M., Muyaya S., Munharo S., Tarning J., Phiri KS., Mwapasa V., ter Kuile FO., Maartens G., Barnes KI.
Volume 66, no. 12, e00584-22, 2022, https://doi.org/10.1128/aac.00584-22. In Fig. 2 and Fig. S1, the first value on the y axis previously read as “0” instead of “1.” The corrected Fig. 2 is shown below. Additionally, revised supplemental material is included with this Erratum. There are no changes to the text or figure legend. (Figure Presented).